About this episode

The episode discusses the challenges and opportunities in improving access to innovative medicines in Canada through collaboration and policy alignment.

While Canadian researchers are making incredible biomedical breakthroughs in labs across the country, our capacity to bring those medicines to patients and their health care teams is inefficient, complex and fragmented. The challenges that currently shape Canada’s access environment are being exacerbated by an increasingly unstable and competitive global marketplace. The result? Without new pathways, new investments and a new commitment to collaboration, too many Canadians will have too little access to breakthrough medicines available to patients in other countries around the world. To deliver world-class care, Canada must align its life sciences ecosystem—from manufacturers and patient groups to policymakers. By harmonizing policy and funding strategies, we can improve equitable access to life-saving innovations for all Canadians. In this episode of From the Burgundy Chairs, Santis Health Senior Advisor Avis Favaro sits down with Dr. Bettina Hamelin, President & CEO of Innovative Medicines Canada. Their conversation focuses on a shared vision for the future: moving past old hurdles through meaningful partnership to support a thriving innovation economy and a healthier…

People in this episode

Host: Avis Favaro

Guest: Dr. Bettina Hamelin

Topics covered

• access to medicines
• biomedical breakthroughs
• health care
• innovation
• collaboration
• life sciences
• policy

Keywords

• Canada
• medicines
• health care
• biomedical
• innovation
• access
• collaboration
• life sciences
• policy

Mentioned in this episode

Organizations: Innovative Medicines Canada

Places: Canada, Ontario

Explore listener stats, chart rankings, contacts and more on the From the Burgundy Chairs podcast page.